(Q37140087)

18 August 2017

1 reference

title

Adjunctive interventions in myocardial infarction: the role of statin therapy (English)

1 reference

18 August 2017

1 reference

myocardial infarction

1 reference

Peter H Jones

1

1 reference

PubMed ID

18417069

18 August 2017

John A Farmer

series ordinal

2

1 reference

PubMed ID

18417069

18 August 2017

language of work or name

1 reference

1 April 2008

1 reference

Current Atherosclerosis Reports

18 August 2017

1 reference

18 August 2017

10

1 reference

18 August 2017

2

1 reference

18 August 2017

142-148

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-008-0021-3

18 August 2017

0 references

cites work

Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11883-008-0021-3

Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects

21 January 2018

1 reference

12 December 2020

Vulnerable plaque: detection and management

1 reference

12 December 2020

The matrix revolutions: matrix metalloproteinase, vasculogenesis, and ischemic tissue repair

1 reference

12 December 2020

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

1 reference

12 December 2020

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

12 December 2020

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

1 reference

12 December 2020

Statins and biomarkers of inflammation

1 reference

12 December 2020

Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial

1 reference

12 December 2020

Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes

1 reference

12 December 2020

A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis

1 reference

12 December 2020

Withdrawal of statins increases event rates in patients with acute coronary syndromes

1 reference

12 December 2020

Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors

1 reference

12 December 2020

Gender-specific correlations of plasminogen activator inhibitor-1 and tissue plasminogen activator levels with cardiovascular disease-related traits

1 reference

12 December 2020

High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit

1 reference

12 December 2020

Early Withdrawal of Statin Therapy in Patients With Non–ST-Segment Elevation Myocardial Infarction National Registry of Myocardial Infarction

1 reference

12 December 2020

Lipid-lowering effects of statins: a comparative review

1 reference

12 December 2020

Long-Term Prognostic Role of Flow-Mediated Dilatation of the Brachial Artery After Acute Coronary Syndromes Without ST Elevation

1 reference

12 December 2020

There is no evidence for an increase in acute coronary syndromes after short-term abrupt discontinuation of statins in stable cardiac patients

1 reference

12 December 2020

New nonlipid effects of statins and their clinical relevance in cardiovascular disease

1 reference

12 December 2020

Time course of systemic markers of inflammation in patients presenting with acute coronary syndromes.

1 reference

12 December 2020

Circulating endothelial progenitor cells, vascular function, and cardiovascular risk

1 reference

12 December 2020

CD40 signaling and plaque instability

1 reference

12 December 2020

Tissue factor in hemostasis and thrombosis

1 reference

12 December 2020

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

12 December 2020

Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trial

1 reference

12 December 2020

Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: reduction of MRNA levels for interleukin-1beta, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor alpha (PPARalpha) in pri

1 reference

12 December 2020

Effect of atorvastatin 80 mg on endothelial cell function (forearm blood flow) in patients with pretreatment serum low-density lipoprotein cholesterol levels <130 mg/dl

1 reference

12 December 2020

Elevated C-reactive protein in acute coronary syndrome presentation is an independent predictor of long-term mortality and heart failure

1 reference

12 December 2020

Atherosclerosis: disease biology affecting the coronary vasculature

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease

1 reference

12 December 2020

Statins and the vascular endothelial inflammatory response

1 reference

12 December 2020

The role of C-reactive protein in cardiovascular disease risk

1 reference

12 December 2020

Pleiotropic effects of statins

1 reference

12 December 2020

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

12 December 2020

10.1007/S11883-008-0021-3

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18417069